Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Giovanni Luca Frassinetti"'
Autor:
Margherita Rimini, Pierfrancesco Franco, Berardino De Bari, Maria Giulia Zampino, Stefano Vagge, Giovanni Luca Frassinetti, Francesca Arcadipane, Almalina Bacigalupo, Martina Valgiusti, Deborah Aloi, Lorenzo Gervaso, Renzo Corvò, Giulia Bartolini, Marianna Alessandra Gerardi, Stefano Cascinu, Andrea Casadei-Gardini
Publikováno v:
Cancers, Vol 13, Iss 4, p 671 (2021)
Anal squamous cell carcinoma (SCC) is a rare tumor, and bio-humoral predictors of response to chemo-radiation (CT-RT) are lacking. We developed a prognostic score system based on laboratory inflammation parameters. We investigated the correlation bet
Externí odkaz:
https://doaj.org/article/0a82faaa05d144dfa022b800224a7ea2
Autor:
Berardino De Bari, Andrea Casadei-Gardini, Almalina Bacigalupo, Giulia Bartolini, Stefano Vagge, Maria Giulia Zampino, Pierfrancesco Franco, Giovanni Luca Frassinetti, Renzo Corvò, Francesca Arcadipane, Stefano Cascinu, Martina Valgiusti, Lorenzo Gervaso, D. Aloi, Margherita Rimini, Marianna Alessandra Gerardi
Publikováno v:
Cancers
Cancers, Vol 13, Iss 671, p 671 (2021)
Volume 13
Issue 4
Cancers, Vol 13, Iss 671, p 671 (2021)
Volume 13
Issue 4
Anal squamous cell carcinoma (SCC) is a rare tumor, and bio-humoral predictors of response to chemo-radiation (CT-RT) are lacking. We developed a prognostic score system based on laboratory inflammation parameters. We investigated the correlation bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493748ebf3e7955e20a99712ea711a3c
Autor:
Giovanni Luca Frassinetti, Emiliano Tamburini, Salvatore Pisconti, Stefania Gori, Nicola Normanno, Maria Alessandra Calegari, Domenico Corsi, A. Cassata, Evaristo Maiello, Angela Damato, Hector Soto Parra, Bruno Daniele, Domenico Bilancia, Armando Orlandi, Maria Giulia Zampino, Lazzaro Repetto, Francesco Ferraù, Francesco Di Costanzo, Carmine Pinto, Alberto Zaniboni, Rosario Vincenzo Iaffaioli, Giuseppe Tonini, Francesca Fenizia, Carlo Barone
Publikováno v:
Future oncology (London, England). 14(14)
The optimal duration and intensity of first-line therapy in metastatic colorectal cancer patients once they have achieved an objective response is controversial. In a molecularly selected RAS and BRAF wild-type (wt) population, this concern is amplif
Autor:
Hector Soto-parra, Francesco Di Costanzo, Carmine Pinto, Rosario Vincenz Iaffaioli, Carlo Barone, Domenico Bilancia, Francesco Ferraù, Alberto Zaniboni, Salvatore Pisconti, Evaristo Maiello, Bruno Daniele, Nicola Normanno, Stefania Gori, M. Giulia Zampino, Giovanni Luca Frassinetti, Lazzaro Repetto, Domenico Corsi, Giuseppe Tonini, Armando Orlandi, Emiliano Tamburini
Publikováno v:
Journal of Clinical Oncology. 35:TPS810-TPS810
TPS810 Background: The optimal duration and content of first-line therapy in mCRC pts once they have achieved objective response is controversial. In the FIRE-3 trial, ETS was significantly associated with PFS and OS. Based on this evidence it can be